Movement Disorders

Researchers gather environmental data to better understand possible mechanisms of Parkinson disease development.

Our Feb. news & research include two new migraine drugs, the stroke-Parkinson link, and the potential of an anticancer drug to prevent Alzheimer.

Our Jan. news & research list includes the possible lingering effects of childhood concussion and the benefits of vitamin D for MS.

Compliance, an obstacle in depression treatment for all patients, can be especially difficult for patients with dementia.

Our Dec. news & research list includes groundbreaking research from AES 2015 as well as a few potential neurodegeneration biomarkers.

A groundbreaking discovery may lead to repair of neurodegenerative diseases such as Alzheimer and Parkinson.

The holidays can be an especially stressful time of year, so patients need to be aware of how stress influences neurological disease progression.

The discovery of a possible trigger for PD and Lewy body dementia could provide a new avenue for gene therapy in these neurological conditions.

Our Nov. news & research list includes 2 successful genetic Alzheimer treatments in mouse models and a potential drug for Parkinson disease psychosis.

A recent webinar summarized on-going efforts to halt Parkinson disease, including several phase III trials.

Dysregulated dopamine may not be the sole cause of impulse control problems in patients with Parkinson disease.

Dopamine may not be the only neurotransmitter affected in Parkinson disease.

A Johns Hopkins team is designing the STIMband, a non-invasive brain-stimulating device that may provide at-home Parkinson treatment.

Researchers test a compound that shows promise as a Parkinson treatment.

Studies of a kuru epidemic in a formerly cannibalistic tribe could lead to further understanding of other neurodegenerative diseases, such as Alzheimer and Parkinson.

Our blogger discusses a recent study investigating the likelihood of head trauma in older patients leading to the onset of Parkinson disease and the implications of the findings.

Patients with PD commonly suffer from depression. A recent cohort study investigated the association between depression and subsequent PD diagnosis.

New PD medications and treatments are being developed and novel uses for existing drugs are being discovered.

Deep brain stimulation, stem cell treatment, studying mitochondria-to mark Parkinson’s Awareness Month, we review some noteworthy new concepts.

Advances in neurology science and patient care continue to make news even before the doors to the AAN 2015 Annual Meeting officially open on Saturday. These are the top stories.

There’s a new app for tracking symptoms of Parkinson disease, Alzheimer and Parkinson diseases may share characteristics with mad cow disease, and a skin test may one day be used to detect both AD and PD.

These agents lower cholesterol and prevent cardiovascular disease, but they may actually increase the risk of Parkinson disease. Caution advised.

Drugs often involve multiple daily doses with complex dosing regimens, but interventions that have been applied generically to patients with chronic diseases can be applied to these cases as well.

Scientists are testing alternative therapeutic approaches that may delay disease progression and even protect and regenerate neurons.

Orexin B protects vulnerable midbrain neurons from degeneration and preserves their function. This sleep-promoting protein could provide a new target for potential treatments.

Men and women smoke for different reasons and activate different parts of the brain while smoking. These findings from “dopamine movies” could have implications for Parkinson disease.

What happens before the demyelinating lesions of MS appear? Does smoking confer protection against Parkinson disease? How is NMDA receptor-associated disease reversed? Here are 4 fine papers from 2014 that set out to answer these questions.